Torrent Pharma Q3 Profit Jumps 26% to ₹635 Cr, Declares ₹29 Dividend

• Torrent Pharmaceuticals reported a 26% YoY increase in Q3 consolidated profit, reaching ₹635 crore from ₹503 crore.
• Consolidated earnings rose from ₹2809 crore to ₹3303 crore, showcasing strength in domestic and international businesses.
• EBITDA increased to ₹1088 crore from ₹914 crore, with margins improving to 32.9% due to cost control and better product mix.
• The company declared an interim dividend of ₹29 per share, signaling strong cash flow and a positive outlook for investors.
• Robust Q3 performance, improved profit, margins, and dividend declaration indicate a strong business position.